Drug companies such as Pfizer Global R&D [22], [23] and Vernalis Ltd [24], [25] as well as several academic laboratories [26], [27], [28], [29], [30] have targeted Pin1 for anti-cancer therapy. Here, PIN1 is linked to cancer.